AI-generated analysis. Always verify with the original filing.
Medicus Pharma Ltd. completed sales of 4,471,038 common shares to Yorkville under the Standby Equity Purchase Agreement dated February 10, 2025, for aggregate consideration of approximately $3,846,910. Part of the net proceeds were used to prepay a portion of an outstanding debenture with Yorkville, with shares issued under Section 4(a)(2) exemption.
Event Type
Disclosure
Mandatory
Variant
8-K
Unregistered Sales of Equity Securities. Pursuant to the previously disclosed Standby Equity Purchase Agreement (the "SEPA"), dated February 10, 2025, between M
.Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104.1 Cover Page Interactive Data File (embedded within the inline XBRL document). 2 F